Product Description
Trimetazidine modified release tablet has been developed to maintain a prolonged coverage in patients with ischaemic heart disease by providing sustained antianginal and anti-ischaemic efficacy round-the-clock. Trimetazidine may be used in patients with angina as add-on therapy. Trimetazidine (TMZ) is an anti-ischemic metabolic agent that has been shown to be efficacious in angina treatment, both in monotherapy and in combination. The trimetazidine modified release tablet is made for use in the treatment of various ailments. The tablet is made for medical purposes.
Advanced Angina ManagementTrimetazidine Modified Release Tablets offer modern treatment solutions for angina pectoris, providing sustained symptom control with a convenient once- or twice-daily dosing schedule. Its modified release technology ensures a consistent release of the active ingredient, contributing to long-lasting anti-ischemic effects for adults managing cardiac conditions.
Trusted Pharmaceutical QualityWith a standard pharmaceutical grade assay of 98.5 - 101.0%, these tablets are manufactured under strict quality guidelines in India. The formulation is free from impurities, appearing white to off-white and freely soluble in water, ensuring rapid absorption and consistent therapeutic action. The tablets are stored securely in cool, dry, and dark environments to maintain potency throughout their 24-month shelf life.
FAQ's of Trimetazidine Modified Release Tablet:
Q: How should Trimetazidine Modified Release Tablets be taken for angina pectoris?
A: Trimetazidine Modified Release Tablets should be taken orally by adults as directed by a physician, typically once or twice daily depending on individual health needs and dosage strength. It is important to follow the prescribed schedule for optimal symptom control.
Q: What benefits does the modified release formulation provide?
A: The modified release design ensures a sustained and steady delivery of trimetazidine, maintaining therapeutic levels in the body for extended periods. This helps achieve long-acting relief from angina symptoms and reduces the frequency of dosing.
Q: When can therapeutic benefits from Trimetazidine tablets be expected?
A: Patients may begin experiencing improved angina symptom management within days of regular use, although optimal benefits are usually observed over continuous treatment as recommended by their healthcare provider.
Q: Where should Trimetazidine Modified Release Tablets be stored to maintain efficacy?
A: Tablets must be stored in a cool, dry, and dark place to preserve their potency and stability throughout the 24-month shelf life. Avoid exposure to sunlight, moisture, or excessive heat.
Q: What is the process for obtaining Trimetazidine Modified Release Tablets?
A: As a prescription medication, these tablets can be obtained through licensed healthcare providers and registered pharmacies. Export, supply, and wholesale options are available from suppliers in India under regulated conditions.
Q: Is Trimetazidine Modified Release suitable for all adults with angina?
A: The tablets are designed for adult patients; however, individual suitability should be assessed by a physician, considering medical history and concurrent medications to ensure safe use.